Trademark: 98010530
Word
TYFLOBA
Status
Pending
Status Code
686
Status Date
Tuesday, February 27, 2024
Serial Number
98010530
Mark Type
4000
Filing Date
Wednesday, May 24, 2023
Published for Opposition
Tuesday, February 27, 2024

Trademark Owner History
Glaxo Group Limited - Owner At Publication

Classifications
5 Vaccines; Anti-infectives; Pharmaceutical preparations and substances for the treatment of damaged skin and tissue; Pharmaceutical preparations for the treatment of infectious diseases, pain, inflammation, obesity and cognitive disorders; Pharmaceutical preparations for the treatment of viral, metabolic, endocrine, musculoskeletal, cardiovascular, cardiopulmonary, genitourinary, oncological, hepatological, respiratory, neurological, gastrointestinal, dermatological, psychiatric and immune system related diseases and disorders

Trademark Events
Mar 4, 2024
Official Gazette Publication Confirmation E-Mailed
Feb 27, 2024
Published For Opposition
Feb 7, 2024
Notification Of Notice Of Publication E-Mailed
Feb 7, 2024
Official Gazette Publication Confirmation E-Mailed
Jan 22, 2024
Approved For Pub - Principal Register
Jan 9, 2024
Assigned To Examiner
Jul 12, 2023
Teas Change Of Correspondence Received
Jul 12, 2023
Applicant/Correspondence Changes (Non-Responsive) Entered
Jul 12, 2023
Teas Change Of Owner Address Received
Jun 14, 2023
New Application Office Supplied Data Entered
May 27, 2023
New Application Entered

Trademark Alertz updated from USPTO on 2030-01-24